Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis

Małgorzata Mikulska, Anna Maria Raiola, Alessio Signori, Elisa Furfaro, Valerio Del Bono, Andrea Bacigalupo, Claudio Viscoli

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1786-1787
Number of pages2
JournalClinical Infectious Diseases
Issue number12
Publication statusPublished - Dec 2013

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this